Omnicell (OMCL) –
-
Omnicell (OMCL) Announces XT Amplify
-
Omnicell Announces XT Amplify
-
Form ARS OMNICELL, INC. For: Dec 31
-
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
-
Form DEF 14A OMNICELL, INC. For: May 21
-
Form 4 OMNICELL, INC. For: Mar 15 Filed by: Manley Corey J
-
Form 4 OMNICELL, INC. For: Mar 15 Filed by: SPEARS JOSEPH BRIAN
-
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
-
Form 4 OMNICELL, INC. For: Feb 27 Filed by: Etta Nchacha
-
Form 4 OMNICELL, INC. For: Feb 27 Filed by: Manley Corey J
-
Form 4 OMNICELL, INC. For: Feb 27 Filed by: LIPPS RANDALL A
-
Form 8-K OMNICELL, INC. For: Feb 23
-
Form 10-K OMNICELL, INC. For: Dec 31
-
Form 4 OMNICELL, INC. For: Feb 15 Filed by: SPEARS JOSEPH BRIAN
-
Form SC 13G/A OMNICELL, INC. Filed by: VANGUARD GROUP INC
-
Omnicell (OMCL) PT Lowered to $40 at Craig-Hallum
-
Omnicell (OMCL) PT Lowered to $26 at Wells Fargo
-
Omnicell (OMCL) PT Lowered to $38 at Benchmark
-
Omnicell (OMCL) PT Lowered to $26 at Barclays
-
Omnicell (OMCL) Tops Q4 EPS by 18c
-
Form 8-K OMNICELL, INC. For: Feb 08
-
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
-
Form 4 OMNICELL, INC. For: Jan 30 Filed by: Scott Bruce E
-
Form 4 OMNICELL, INC. For: Jan 30 Filed by: Voynick Eileen J.
-
Form SC 13G/A OMNICELL, INC. Filed by: BlackRock Inc.
-
Form 3 OMNICELL, INC. For: Jan 05 Filed by: Voynick Eileen J.
-
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
-
Form 8-K OMNICELL, INC. For: Jan 05
-
Omnicell (OMCL) Appoints Eileen Voynick to its Board
-
Omnicell Elects Eileen Voynick to Board of Directors
-
Barclays Starts Omnicell (OMCL) at Underweight
-
Form 4 OMNICELL, INC. For: Dec 15 Filed by: SPEARS JOSEPH BRIAN
-
Form 4 OMNICELL, INC. For: Dec 15 Filed by: LIPPS RANDALL A
-
Form 4 OMNICELL, INC. For: Dec 15 Filed by: Manley Corey J
-
Form SC 13G/A OMNICELL, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
-
Form 4 OMNICELL, INC. For: Nov 15 Filed by: SPEARS JOSEPH BRIAN
-
Form 8-K OMNICELL, INC. For: Nov 03
-
Omnicell (OMCL) PT Lowered to $28 at JPMorgan
-
Form 10-Q OMNICELL, INC. For: Sep 30
-
Omnicell (OMCL) PT Lowered to $49 at BofA Securities
-
Omnicell (OMCL) PT Lowered to $50 at Craig-Hallum
-
Omnicell (OMCL) PT Lowered to $42 at Benchmark
-
Wells Fargo Upgrades Omnicell (OMCL) to Equal Weight
-
BTIG Downgrades Omnicell (OMCL) to Neutral
-
Piper Sandler Upgrades Omnicell (OMCL) to Overweight, 'a buying opportunity'
-
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
-
Form 8-K OMNICELL, INC. For: Nov 02
-
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
-
Form 8-K OMNICELL, INC. For: Oct 10
Back to OMCL Stock Lookup